American Brain Tumor Association AI policy

For applicants

• The use of generative AI is allowed for ABTA grant applications. Applicants are fully responsible for the content and are encouraged to thoroughly review anything an AI tool creates.[1]
• For Metastatic Brain Tumor Collaborative grants, any publishable content (such as the lay summary) must be authored by, or developed from information authored by, the applicant or others working on the project.[2]

For reviewers

• For Metastatic Brain Tumor Collaborative grants, review committee chairs and reviewers (scientific and patient advocate) may not use AI to analyze, summarize, interpret, or formulate critiques of applications.[2]

Sources

1. [1]

   ABTA Research Collaboration Grants

   American Brain Tumor Association

   “The use of Generative Artificial Intelligence (AI) is allowed for ABTA grant applications. Applicants are fully responsible for the content of their applications and are encouraged to thoroughly review any content created by an AI tool.”

2. [2]

   Policies and Procedures for 2027 Metastatic Brain Tumor Collaborative Grants

   American Brain Tumor Association / Metastatic Brain Tumor Collaborative, October 23, 2024

   “Any publishable content (i.e. lay summary) MUST be authored by, or developed using information authored by, the Applicant or others working on the project.”

   “Review Committee Chairpersons and Reviewers, including Scientific Reviewers and Patient Advocate Reviewers, are not permitted to use AI technologies for analyzing and formulating peer review critiques for grant applications, including for the purpose of summarizing the application or for interpreting the information in the application.”